Literature DB >> 26673100

Should we be promoting embryo transfer at blastocyst stage?

Abha Maheshwari1, Mark Hamilton2, Siladitya Bhattacharya3.   

Abstract

Improved laboratory standards and better culture media have made extended culture to blastocyst stage a reality to identify embryos with maximum implantation potential. The strategy of extended culture has become more popular across the world at a time when regulatory bodies have emphasized the need to increase the uptake of elective single embryo transfer, minimize complications associated with multiple births and aim for a healthy singleton live-birth as the preferred outcome in IVF. New data on perinatal outcomes suggest that pregnancies after embryo transfer at blastocyst stage are associated with a higher risk of preterm delivery, large for gestational age babies, monozygotic twins and altered sex ratio compared with those following embryo transfers at cleavage stage. In addition, concerns have been raised of increased congenital anomalies and epigenetic modifications with embryo transfer at blastocyst stage. Twenty-four years on from the first embryo transfer at blastocyst stage, we examine the reasons for extended embryo culture, evaluate the risks and benefits of this strategy and suggest the need to reconsider this policy in the interests of fetal safety.
Copyright © 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IVF; blasocyst; embryo transfer; preterm delivery

Mesh:

Year:  2015        PMID: 26673100     DOI: 10.1016/j.rbmo.2015.09.016

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  31 in total

1.  No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study.

Authors:  Paolo Emanuele Levi-Setti; Federico Cirillo; Antonella Smeraldi; Emanuela Morenghi; Giulia E G Mulazzani; Elena Albani
Journal:  J Assist Reprod Genet       Date:  2017-11-22       Impact factor: 3.412

2.  Improvement of pregnancy outcome by extending embryo culture in IVF-ET during clinical application.

Authors:  Xiaopeng Zhao; Binbin Ma; Shaokang Mo; Lu Ma; Fei Chang; Liyuan Zhang; Fang Xu; Ling Wang
Journal:  J Assist Reprod Genet       Date:  2017-11-09       Impact factor: 3.412

3.  Effect of frozen/thawed embryo transfer on birthweight, macrosomia, and low birthweight rates in US singleton infants.

Authors:  Julia F Litzky; Sheree L Boulet; Navid Esfandiari; Yujia Zhang; Dmitry M Kissin; Regan N Theiler; Carmen J Marsit
Journal:  Am J Obstet Gynecol       Date:  2017-12-29       Impact factor: 8.661

4.  High grade trophectoderm is associated with monozygotic twinning in frozen-thawed single blastocyst transfer.

Authors:  Shiru Xu; Qizhen Zheng; Meilan Mo; Feng Xiong; Xiuyu Hu; Yong Zeng
Journal:  Arch Gynecol Obstet       Date:  2021-02-03       Impact factor: 2.344

Review 5.  Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology.

Authors:  Demián Glujovsky; Andrea Marta Quinteiro Retamar; Cristian Roberto Alvarez Sedo; Agustín Ciapponi; Simone Cornelisse; Deborah Blake
Journal:  Cochrane Database Syst Rev       Date:  2022-05-19

Review 6.  Multi-chorionic pregnancies following single embryo transfer at the blastocyst stage: a case series and review of the literature.

Authors:  Viji Sundaram; Salustiano Ribeiro; Martha Noel
Journal:  J Assist Reprod Genet       Date:  2018-10-25       Impact factor: 3.412

7.  Prevalence of a Good Perinatal Outcome With Cryopreserved Compared With Fresh Donor Oocytes.

Authors:  Jennifer L Eaton; Tracy Truong; Yi-Ju Li; Alex J Polotsky
Journal:  Obstet Gynecol       Date:  2020-03       Impact factor: 7.623

Review 8.  Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review.

Authors:  Stefano Palomba; Roy Homburg; Susanna Santagni; Giovanni Battista La Sala; Raoul Orvieto
Journal:  Reprod Biol Endocrinol       Date:  2016-11-04       Impact factor: 5.211

9.  A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use.

Authors:  Norbert Gleicher; Jacob Metzger; Gist Croft; Vitaly A Kushnir; David F Albertini; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2017-04-27       Impact factor: 5.211

10.  Preimplantation genetic screening- the required RCT that has not yet been carried out.

Authors:  Raoul Orvieto
Journal:  Reprod Biol Endocrinol       Date:  2016-06-24       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.